Belize vs Fiji: Cause of death, by non-communicable diseases, ages 60+, female
Belize
73.7%
in 2021
Fiji
73.5%
in 2021
Belize rank
97th
Fiji rank
100th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Belize
- Fiji
How they compare
Belize currently reports 73.7% against 73.5% in Fiji, a difference of 0.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Fiji ahead.
Belize ranks 97th and Fiji ranks 100th of 185 countries.
Fiji has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 88.0% | 91.5% | 3.5% | Fiji |
| 2010s | 87.5% | 92.9% | 5.4% | Fiji |
| 2020s | 78.6% | 82.7% | 4.1% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Belize or Fiji?
- Belize, at 73.7% against 73.5% in Fiji as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Belize and Fiji?
- 0.2%, with Belize ahead.
- How many years of comparable data are there for Belize and Fiji?
- 6 years are reported by both, from 2000 to 2021.
- How do Belize and Fiji rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Belize ranks 97th and Fiji ranks 100th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.